Gestational diabetes can be defined as a type of diabetes that affects pregnant women. It is usually a temporary condition which develops during pregnancy and subsides after the birth of the baby. However, there are possibilities that diabetes may return in the later stages of life as type II diabetes mellitus. It is the inability of insulin to absorb the sugars consumed as part of the meal. It may be caused due to insulin resistance in a woman’s body because of increasing levels of placental hormones being produced to sustain the development of the fetus. This condition starts when the female body is not able to make and use required amounts of insulin needed in pregnancy, resulting in a build-up of sugar in the bloodstream causing hyperglycemia. According to a case study published by the World Diabetes Foundation, gestational diabetes is an undertreated condition and affects nearly 18 million women each year. It is known to impact over 14% of the pregnancies globally and over 18 million live births every year. Risk factors associated with the condition include overweight babies, risk of developing diabetes mellitus in the later stages of life, birth trauma, respiratory distress, pre-eclampsia, hypocalcemia, and glucose-mediated macrosomia.
The global gestational diabetes treatment market is anticipated to grow during the forecast period driven by increase in prevalence of the condition in the population. According to the American Pregnancy Association, over 2% to 5% of the pregnant women in the U.S. suffer from gestational diabetes, which is likely to rise to 7% to 9% in the near future. Changing lifestyle habits, increasing obesity, delayed pregnancies, and rise in screening for gestational diabetes during prenatal testing contribute to the growth of the market. However, lack of awareness among the people and non-symptomatic nature of the condition are likely to hamper market growth.
The global gestational diabetes treatment market can be segmented based on drug class, mode of administration, distribution channel, and region. In terms of drug class, the market can be categorized into insulin, alpha-glucosidase inhibitors, SGLT-2 inhibitors, and others. Insulin therapy is the most preferred mode of treatment due to its effectiveness in treating the diabetic condition. Based on mode of administration, the global gestational diabetes treatment market can be classified into oral, intravenous, and others. Intravenous mode of administration is mostly preferred owing to the fact that insulin, the commonly employed treatment for gestational diabetes is administered intravenously. In terms of distribution channel, the market can be divided into hospital pharmacies, retail pharmacies, and others.
Geographically, the global gestational diabetes treatment market can be segmented into five major regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America accounted for the largest share of the global market in terms of revenue in 2016. The trend is anticipated to continue during the forecast period. Strong growth in the region can be attributed to rise in prevalence of gestational diabetes among the population and ongoing efforts on spreading awareness among the people. Europe is expected to be the second leading market for gestational diabetes treatment. However, the sluggish economy in the region is likely to negatively impact the growth of the market. The market in Asia Pacific is anticipated to record a significantly high CAGR due to high patient population, rise in government focus on enhancing health care facilities, and increase in product approvals.
Leading players operating in the global gestational diabetes treatment market are Biocon Limited, Eli Lilly and Company, Novo Nordisk, Boehringer Ingelheim GmbH, Sanofi S.A., Sun Pharmaceutical Industries Limited, Merck & Co., Inc., Novartis International AG, Adocia, Peptron, AstraZeneca plc, Pfizer, Inc., Takeda Pharmaceutical Company Ltd., and Abbott Laboratories, among others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.